Nektar Therapeutics NKTR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's net income?
- Nektar Therapeutics (NKTR) reported net income of -$44.9M in Q1 2026.
- How has Nektar Therapeutics's net income changed year-over-year?
- Nektar Therapeutics's net income increased by 11.7% year-over-year, from -$50.88M to -$44.9M.
- What is the long-term trend for Nektar Therapeutics's net income?
- Over 4 years (2021 to 2025), Nektar Therapeutics's net income has grown at a -25.2% compound annual growth rate (CAGR), from -$523.84M to -$164.08M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.